New Dedicated HCPCS Codes for MyoStrain® and MyoStress™
The codes come into effect today, July 1, 2020. Read more about the codes in our latest news release.
Read News ReleaseThe codes come into effect today, July 1, 2020. Read more about the codes in our latest news release.
Read News Release
Myocardial Solutions, Inc. (MSI), who has pioneered the quantification of segmental cardiac strain testing to transform how physicians manage and monitor patient heart health, announced today that the Centers for Medicare and Medicaid Services (CMS) has issued unique codes for MSI’s...
June 23, 2020
The PROactive evaluation of function to Avoid Cardio-Toxicity (PROACT; NCT03862131) clinical trial has started at Washington University School of Medicine and Yale New Haven Hospital with patients receiving baseline MyoStrain exams before chemotherapy treatment. The study will evaluate the...
June 13, 2019
Myocardial Solutions’ MyoStrain was featured in two different posters presented at the European Society of Cardiology's annual Heart Failure Congress 2019. The event was held in Athens, Greece on May 25-28, 2019. The lead author of the abstracts was Dr. Henning Steen, Head of Cardiac Imaging at...
May 29, 2019
Myocardial Solutions provided MyoStrain cardiac function exams to attendees of the 2019 Hauptstadt Congress for Medicine and Health (Hauptstadt Kongress) in Berlin, Germany from Mary 21st – 23rd. In collaboration with medneo GmbH, Berlin Heart Institute and Philips, MyoStrain provided scan...
May 23, 2019
Three posters utilizing Myocardial Solutions’ MyoStrain® were presented at the annual European Magnetic Cardiovascular Resonance (EuroCMR) Congress 2019. The event was held in Venice, Italy on May 2-4, 2019. The posters covered the following...
May 5, 2019
Myocardial Solutions’ MyoStrain was featured in four different abstracts presented at the 85th Annual Conference of the German Society of Cardiology (DGK). The event was held in Mannheim, Germany on April 24th-27th, 2019. The abstracts addressed the multiple uses for MyoStrain across indications...
April 28, 2019
A clinical review article that describes the history and evolution of MyoStrain was published in the ESC Heart Failure journal. The Manuscript, titled: “Strain‐encoded magnetic resonance: a method for the assessment of myocardial deformation”, summarizes the existing literature on the MyoStrain...
April 25, 2019
Myocardial Solutions (MSI) has hired Rafael Rivero, MD as Global Head of Medical Affairs. Rafael’s focus is on expanding utilization and advocacy of MSI’s cardiac diagnostic software, MyoStrain®, in the medical community. Rafael brings over 17 years of experience leading and transforming both...
April 8, 2019
Myocardial Solutions’ MyoStrain was featured in two different abstracts that were presented at the American College of Cardiology’s 68th Annual Scientific Session & Expo. The event was held in New Orleans, Louisiana on March 16th – 18th, 2019.One abstract was based on a study completed at Sharon...
March 19, 2019
After its initial closing of $6.6 million in December, Myocardial Solutions, Inc. has rounded out and completed its’ Series C financing round of $7.0 million of equity investment. The funding round was led by a family office. The company has now raised a total of $16.0 million since it was...
March 6, 2019
We're here to answer your questions. Learn how MyoStrain can help transform your cardiac practice.
